Improved oral delivery of N-(4 -hydroxyphenyl )retinamide with a novel LYM-X-SORB organized lipid complexMAURER, Barry J; KALOUS, Ondrej; BURGESS, Stephen W et al.Clinical cancer research. 2007, Vol 13, Num 10, pp 3079-3086, issn 1078-0432, 8 p.Article

Total rod ERG suppression with high dose compassionate Fenretinide usageMARMOR, Michael F; JAIN, Atul; MOSHFEGHI, Darius et al.Documenta ophthalmologica. 2008, Vol 117, Num 3, pp 257-261, issn 0012-4486, 5 p.Article

Targeting homeostatic mechanisms of endoplasmic reticulum stress to increase susceptibility of cancer cells to fenretinide-induced apoptosis : the role of stress proteins ERdj5 and ERp57CORAZZARI, M; LOVAT, P. E; ARMSTRONG, J. L et al.British journal of cancer. 2007, Vol 96, Num 7, pp 1062-1071, issn 0007-0920, 10 p.Article

Fenretinide inhibits HIV infection by promoting viral endocytosisFINNEGAN, Catherine M; BLUMENTHAL, Robert.Antiviral research. 2006, Vol 69, Num 2, pp 116-123, issn 0166-3542, 8 p.Article

N-(4-Hydroxylphenyl)retinamide (fenretinide, 4-HPR), a retinoid compound with antileukemic and proapoptotic activity in acute lymphoblastic leukemia (ALL)FADERL, Stefan; LOTAN, Reuben; KANTARJIAN, Hagop M et al.Leukemia research. 2003, Vol 27, Num 3, pp 259-266, issn 0145-2126, 8 p.Article

Fenretinide as an anti-angiogenic agent in neuroblastomaRIBATTI, Domenico; RAFFAGHELLO, Lizzia; MARIMPIETRI, Danilo et al.Cancer letters. 2003, Vol 197, Num 1-2, pp 181-184, issn 0304-3835, 4 p.Article

Pharmacokinetics of oral fenretinide in neuroblastoma patients : indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinideFORMELLI, Franca; CAVADINI, Elena; LUKSCH, Roberto et al.Cancer chemotherapy and pharmacology. 2008, Vol 62, Num 4, pp 655-665, issn 0344-5704, 11 p.Article

HER2/neu reduces the apoptotic effects of N-(4-hydroxyphenyl)retinamide (4-HPR) in breast cancer cells by decreasing nitric oxide productionSIMEONE, Ann-Marie; BROEMELING, Lyle David; ROSENBLUM, Josh et al.Oncogene (Basingstoke). 2003, Vol 22, Num 43, pp 6739-6747, issn 0950-9232, 9 p.Article

Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposureCOOPER, Jason P; HWANG, Kyunghwa; SINGH, Hardeep et al.British journal of pharmacology. 2011, Vol 163, Num 6, pp 1263-1275, issn 0007-1188, 13 p.Article

Alteration of retinol-binding-protein concentrations by the synthetic retinoid fenretinide in healthy human subjectsDIMITROV, N. V; MEYER, C. J; PERLOFF, M et al.The American journal of clinical nutrition. 1990, Vol 51, Num 6, pp 1082-1087, issn 0002-9165, 6 p.Article

Ocular toxic effects of fenretinideMODIANO, M. R; DALTON, W. S; LIPPMAN, S. M et al.Journal of the National Cancer Institute. 1990, Vol 82, Num 12, issn 0027-8874, p. 1063Article

Effects of manipulation of the caspase system on myofibrillar protein degradation in vitroKEMP, C. M; WHEELER, T. L.Journal of animal science. 2011, Vol 89, Num 10, pp 3262-3271, issn 0021-8812, 10 p.Article

Evaluation of a mucoadhesive fenretinide patch for local intraoral delivery: a strategy to reintroduce fenretinide for oral cancer chemopreventionHOLPUCH, Andrew S; PHELPS, Maynard P; BORDER, Michael B et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 5, pp 1098-1105, issn 0143-3334, 8 p.Article

Identification of mammalian target of rapamycin as a direct target of fenretinide both in vitro and in vivoHUA XIE; FENG ZHU; REDDY, Kanamata et al.Carcinogenesis (New York. Print). 2012, Vol 33, Num 9, pp 1814-1821, issn 0143-3334, 8 p.Article

Hypoxia-mediated fenretinide (4-HPR) resistance in childhood acute lymphoblastic leukemia cellsBO YANG; LINGLING FAN; LIANG FANG et al.Cancer chemotherapy and pharmacology. 2006, Vol 58, Num 4, pp 540-546, issn 0344-5704, 7 p.Article

Fenretinide cytotoxicity for Ewing's sarcoma and primitive neuroectodermal tumor cell lines is decreased by hypoxia and synergistically enhanced by ceramide modulatorsBATRA, Sandeep; REYNOLDS, C. Patrick; MAURER, Barry J et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5415-5424, issn 0008-5472, 10 p.Article

Potent effect of 5-HPBR, a butanoate derivative of 4-HPR, on cell growth and apoptosis in cancer cellsHAN, Hye-Sook; KWON, Your-Ja; PARK, Si-Ho et al.International journal of cancer. 2004, Vol 109, Num 1, pp 58-64, issn 0020-7136, 7 p.Article

Bak: A downstream mediator of fenretinide-induced apoptosis of SH-SY5Y neuroblastoma cellsLOVAT, Penny E; OLIVERIO, Serafina; CORAZZARI, Marco et al.Cancer research (Baltimore). 2003, Vol 63, Num 21, pp 7310-7313, issn 0008-5472, 4 p.Article

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancerVERONESI, U; DE PALO, G; MURACA, M. G et al.Journal of the National Cancer Institute. 1999, Vol 91, Num 21, pp 1847-1856, issn 0027-8874Article

Regulation of lipocalin-2 gene by the cancer chemopreventive retinoid 4-HPRCARAMUTA, Stefano; DE CECCO, Loris; REID, James F et al.International journal of cancer. 2006, Vol 119, Num 7, pp 1599-1606, issn 0020-7136, 8 p.Article

Efficacy of 9-cis-retinoic acid and N-(4-hydroxyphenyl) retinamide alone and in combination in mammary cancer preventionCOPE, Mark B; STEELE, Vernon E; LUBET, Ronald A et al.Oncology reports. 2004, Vol 11, Num 2, pp 465-469, issn 1021-335X, 5 p.Article

Phase I trial and pharmacokinetics of Fenretinide in children with neuroblastomaGARAVENTA, Alberto; LUKSCH, Roberto; BELLANI, Franca Fossati et al.Clinical cancer research. 2003, Vol 9, Num 6, pp 2032-2039, issn 1078-0432, 8 p.Article

Induction of cytochrome P450 3A by retinoids in rat hepatocyte cultureJURIMA-ROMET, M; NEIGH, S; CASLEY, W et al.Human & experimental toxicology. 1997, Vol 16, Num 4, pp 198-203, issn 0960-3271Article

Retinoid receptor-dependent and independent biological activities of novel fenretinide analogues and metabolitesSABICHI, Anita L; HUI XU; FISCHER, Susan et al.Clinical cancer research. 2003, Vol 9, Num 12, pp 4606-4613, issn 1078-0432, 8 p.Article

Fenretinide : Induction of apoptosis and endogenous transforming growth factor β in PC-3 prostate cancer cellsROBERSON, K. M; PENLAND, S. N; PADILLA, G. M et al.Cell growth and differentiation. 1997, Vol 8, Num 1, pp 101-111, issn 1044-9523Article